Inozyme Pharma’s Post

View organization page for Inozyme Pharma, graphic

6,798 followers

We are at the American Society for Bone and Mineral Research (ASBMR) 2024 Annual Meeting in Toronto, Canada, through this weekend!    We are thrilled to connect with colleagues, peers, and partners to discuss the many unmet needs in bone and mineralization diseases.     If you are attending, stop by our booth to learn more about our work to develop potential treatments for #ENPP1 and #ABCC6 Deficiencies.     #ASBMR2024 #RareDiseases 

  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
Matt Winton

Chief Operating Officer (COO) at Inozyme Pharma | >15 years of leadership experience in biotech/pharma industry | Passionate about developing and commercializing innovative therapies for rare and hard to treat diseases

1mo

Good looking team!

Tara Panetta, PharmD

Vice President, Commercial Strategy and Operations, Rare Disease

1mo

Dream team

Daphne Plump

Executive Director | Human Growth Foundation (HGF) | Dedicated to driving HGF forward through the transformative power of commitment, compassion, and collaboration through every challenge and victory.

1mo

💚

Like
Reply
Diaa Diab

Director | Global Medical Affairs | Hematology & Nephrology | Rare diseases | Boston, USA

1mo

Amazing Katie! & the team.

See more comments

To view or add a comment, sign in

Explore topics